Bionics Institute welcomes Dr Sherryl Wagstaff to Board

13 August 2020

Dr Sherryl Wagstaff (MBBS, FRACS MBA (MBS) GAICD), an ear-nose-and-throat (ENT) specialist and Medical Director at Epworth Eastern Hospital recently joined the Board of the Bionics Institute. Dr Wagstaff has been working with the Bionics Institute’s hearing therapeutics team for the past two years.

As an otolaryngologist, Dr Wagstaff has seen thousands of patients experience hearing loss. From her clinical experience, everyone will acquire some degree of hearing loss as they get older, but to what extent depends on various factors. Over time hearing loss can make people feel disconnected and overwhelmed and, as a result, many patients simply withdraw from society. The Institute’s hearing therapeutics research team, led by A/Prof Andrew Wise and Dr Wagstaff, are working on the development of a novel technology that may be able to stop the progression of hearing loss, and even improve the hearing loss that has already occurred. The technology uses nano-engineering to create tiny particles that can slowly deliver therapeutic agents into the inner ear in a safe and effective way.

In the past, Dr Wagstaff has told her patients that the idea of a drug that could assist with hearing loss would never happen in their lifetime. After collaborating with the Institute, she is now filled with a sense of confidence that one day soon she will have a hearing loss treatment to offer her patients that will provide life-changing benefits. This has provided Dr Wagstaff with a great deal of inspiration for both herself and her patients. She has a sense of satisfaction that the collaboration with the Institute has been instrumental in an incredible advancement in hearing impairment research.

“I have felt that my interactions with the Institute’s scientists are mutually beneficial. I don’t think that one can live without the other anymore. Australia has both worldclass scientists and world-class clinicians. It is time that we recognize that the interaction between the two groups is the only way to progress science at a speed that makes it relevant to patients. Success is no longer about journal articles and citations; it is about touching patients to enhance their lives forever.” — DR SHERRYL WAGSTAFF

Read more news from the Bionics Institute in their Winter Newsletter. 


News & opinion

Member Directory